DK426588A - Fremgangsmaade til paavisning af celleoverfladeantigen - Google Patents

Fremgangsmaade til paavisning af celleoverfladeantigen

Info

Publication number
DK426588A
DK426588A DK426588A DK426588A DK426588A DK 426588 A DK426588 A DK 426588A DK 426588 A DK426588 A DK 426588A DK 426588 A DK426588 A DK 426588A DK 426588 A DK426588 A DK 426588A
Authority
DK
Denmark
Prior art keywords
cell surface
surface antigen
procedure
detecting cell
present
Prior art date
Application number
DK426588A
Other languages
English (en)
Other versions
DK426588D0 (da
DK173838B1 (da
Inventor
Robert Mcmillan
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/936,125 external-priority patent/US4810632A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK426588D0 publication Critical patent/DK426588D0/da
Publication of DK426588A publication Critical patent/DK426588A/da
Application granted granted Critical
Publication of DK173838B1 publication Critical patent/DK173838B1/da

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/29—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the position or the direction of light beams, i.e. deflection
    • G02F1/31—Digital deflection, i.e. optical switching
    • G02F1/313—Digital deflection, i.e. optical switching in an optical waveguide structure
    • G02F1/3131—Digital deflection, i.e. optical switching in an optical waveguide structure in optical fibres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/3515—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam
    • G02F1/3517—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer
    • G02F1/3519—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer of Sagnac type, i.e. nonlinear optical loop mirror [NOLM]
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F3/00—Optical logic elements; Optical bistable devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Power Engineering (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DK198804265A 1986-12-01 1988-07-29 Fremgangsmåde til påvisning af tilstedeværelsen af et blodpladecelleoverfladeantigen DK173838B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US06/936,125 US4810632A (en) 1986-12-01 1986-12-01 Cell surface antigen detection method
US93612586 1986-12-01
US12490587 1987-11-24
US07/124,905 US5176998A (en) 1986-12-01 1987-11-24 Cell surface antigen detection method
PCT/US1987/003129 WO1988004432A1 (en) 1986-12-01 1987-11-25 Cell surface antigen detection method
US8703129 1987-11-25

Publications (3)

Publication Number Publication Date
DK426588D0 DK426588D0 (da) 1988-07-29
DK426588A true DK426588A (da) 1988-07-29
DK173838B1 DK173838B1 (da) 2001-12-10

Family

ID=26823073

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804265A DK173838B1 (da) 1986-12-01 1988-07-29 Fremgangsmåde til påvisning af tilstedeværelsen af et blodpladecelleoverfladeantigen

Country Status (9)

Country Link
US (2) US5176998A (da)
EP (1) EP0290595B1 (da)
JP (1) JP2803824B2 (da)
AT (1) ATE123341T1 (da)
AU (1) AU594554B2 (da)
DE (1) DE3751331T2 (da)
DK (1) DK173838B1 (da)
FI (1) FI95082C (da)
NO (1) NO172910C (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method
US5525461A (en) * 1991-11-01 1996-06-11 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using total leukocyte surface antigens
US5731425A (en) * 1994-10-28 1998-03-24 Eastman Kodak Company Polypeptide surface marker for cells
US6984526B2 (en) 1995-02-08 2006-01-10 University Of South Florida Spectrophotometric method for determining the viability of a sample containing platelets
US6330058B1 (en) 1999-04-14 2001-12-11 University Of South Florida Spectrophotometric method and apparatus for blood typing
US6379903B1 (en) * 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
WO2010065425A1 (en) 2008-12-01 2010-06-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detection of complement fixing antibodies
WO2012070964A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Модифицированные олигопептиды с противораковыми свойствами и способ их получения
EP3435080A1 (en) 2013-03-14 2019-01-30 The Board of Trustees of the Leland Stanford Junior University Methods of detecting donor-specific antibodies
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4643971A (en) * 1983-03-11 1987-02-17 Sloan-Kettering Institute Monoclonal antibodies to human bladder and ureter cancers and method
EP0149168B1 (en) * 1983-12-19 1991-04-24 Daiichi Pure Chemicals Co. Ltd. Immunoassay
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
JPS6181798A (ja) * 1984-07-23 1986-04-25 ベクトン・デイツキンソン・アンド・カンパニ− 細胞リセプタ−の回収
US4670394A (en) * 1984-11-16 1987-06-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method

Also Published As

Publication number Publication date
DK426588D0 (da) 1988-07-29
EP0290595A4 (en) 1990-12-19
ATE123341T1 (de) 1995-06-15
AU1087688A (en) 1988-06-30
NO883367D0 (no) 1988-07-29
DE3751331T2 (de) 1996-02-01
DK173838B1 (da) 2001-12-10
NO172910B (no) 1993-06-14
FI95082B (fi) 1995-08-31
US5336597A (en) 1994-08-09
FI883585A0 (fi) 1988-07-29
DE3751331D1 (de) 1995-07-06
NO883367L (no) 1988-07-29
US5176998A (en) 1993-01-05
NO172910C (no) 1993-09-22
FI95082C (fi) 1995-12-11
EP0290595B1 (en) 1995-05-31
FI883585L (fi) 1988-07-29
AU594554B2 (en) 1990-03-08
JPH01501571A (ja) 1989-06-01
EP0290595A1 (en) 1988-11-17
JP2803824B2 (ja) 1998-09-24

Similar Documents

Publication Publication Date Title
DK158481C (da) Fremgangsmaade til analyse af antistoffer samt reagens dertil
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
DK426588A (da) Fremgangsmaade til paavisning af celleoverfladeantigen
KR880700938A (ko) 인간말초 혈액에서 백혈구의 회수를 위한 단일 클론 항체 및 이 단일 클론 항체를 이용한 백혈구의 회수 방법
ES2176347T3 (es) Modulacion de la respuesta inmune.
NO331074B1 (no) Analysemetode for bestemmelse av holo-Transcobalamin II i en cellefri prove i et kroppsfluid.
DE3270252D1 (en) Radioimmunoassay for fibrinopeptide a
DE3674933D1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
ES8501530A1 (es) Metodo de ensayo de anticuerpos.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
EP0271810A3 (en) Immunological determination of free human protein s and c4bp-protein s complex
DK467888D0 (da) Fremgangsmaade til fiksering af et antigen eller antistof samt et protein paa en baerer, saaledes overtrukket baerer og dens anvendelse.
SE8304190D0 (sv) Forfarande och reagens for immunologiska metningar
GR900100550A (el) Μία μέ?οδος για την αναστολή της αντιγραφής ιού σε κύτταρα ?ηλαστικών χρησιμοποιώντας συζυγείς πρωτεϊνης αντιιού φυτολάκκας - μονοκλωνικού αντισώματος.
DK230485A (da) Fremgangsmaade til bestemmelse af atl virusantistof og reagens dertil
DK582288D0 (da) Analysefremgangsmaade og saet til udfoerelse af fremgangsmaaden
NO881998L (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker og middel til gjennomfoering av fremgangsmaaten.
DK305084A (da) Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired